Anti-HER2 isotype family

The Anti-HER2 isotype family features the variable region of trastuzumab.Trastuzumab is a humanized IgG1 monoclonal antibody that targets the HER2 receptor (also known as HER2/neu) that is found on the cell membrane of epithelial cells. HER2 plays an important role in normal cell growth and differentiation. However, in certain types of cancers, particularly in breast and ovarian cancers, HER2 is over-expressed and causes uncontrollable cell proliferation. Binding of trastuzumab to HER2 results in cell death through different mechanisms including antibody-dependent cell-mediated cytotoxicity and phagocytosis. Trastuzumab has been approved by the FDA for the treatment of breast cancer.

The Anti-HER2 isotype family was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography: protein G for IgG1 and IgG4, and peptide M for IgA2.

Anti-HER2-Tra-hIgG1HER2 (trastuzumab) antibody - Human IgG1100 µg
Anti-HER2-Tra-hIgG4 (S228P)HER2 (trastuzumab) antibody - Human IgG4 (S228P)100 µg
Anti-HER2-Tra-hIgA2HER2 (trastuzumab) antibody - Human IgA2100 µg
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "".